The Cigna Group (CI) Earnings

The Cigna Group

CI · NYSE

Sep 2026upcoming

Next quarter

Consensus is $7.50 EPS for Sep 2026 across 7 estimates, ranging $7.44 to $7.66.

CI Jun 2026

Reported Jul 30, 2026

Beat 2.64%

EPS estimate: $7.58
EPS actual: $7.78
Revenue estimate: —
Revenue actual: —
1-day move: -2.99%

Call highlights have not been generated for this quarter.

Symbol: CI
Type: Stock
Sector: Health Care
Industry: Medical Specialities
Country: North America
Exchange: NYSE

Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the health care system, empowering them with the information and insight they need to make the best choices for improving their health and vitality. Products and services are provided exclusively by or through operating subsidiaries of The Cigna Group (NYSE:CI), including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Health companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and others.

Key Issues

Bullish view

Cigna delivered an earnings and revenue beat, with Cigna Healthcare fueling growth and both Evernorth and Cigna Healthcare exceeding management expectations in the second quarter.

Bearish view

Higher pharmacy costs remain a specific pressure cited in the earnings coverage and could restrain profit conversion even as operating performance improves.

Analyst Consensus

See all

Buy

21 analysts

$271

Current

—

Low

$340

Average

—

High

Average target implies +25.42% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Regeneron Pharmaceuticals, Inc.REGN · NASDAQ-GS$770.36